Back to index
Praxis Precision Medicines, Inc.

Praxis Precision Medicines, Inc.

praxismedicines.comBiopharmaceutical

What AI says about Praxis Precision Medicines, Inc.

Praxis Precision Medicines is dedicated to advancing precision therapies for CNS disorders, leveraging insights from genetic epilepsies. Their mission is to deliver life-altering treatments efficiently and effectively to patients in need.

Is this your brand?

Claim this profile to keep your information accurate and add what's missing.

Not in this profile yet:

Company details

Products & Services

Precision Therapies for CNS Disorders

A portfolio of clinical-stage therapies aimed at treating central nervous system disorders characterized by neuronal excitation-inhibition imbalance.

Common Questions

What is the mission of Praxis Precision Medicines?

Praxis aims to help patients by delivering life-altering treatments faster and more effectively than ever before.

What types of disorders does Praxis focus on?

Praxis focuses on central nervous system disorders, particularly those related to genetic epilepsies.

How does Praxis approach drug development?

Praxis utilizes a patient-guided development strategy and focuses on therapeutic targets identified through human genetics.

Who are the key leaders at Praxis?

The leadership team includes experienced professionals in genetics, biology, chemistry, and business, with Marcio Souza as the CEO.

What is the company's approach to clinical development?

Praxis pursues efficient and rigorous clinical development paths to achieve proof-of-concept in humans.

Company Information

Employees
unknown
Industries
BiopharmaceuticalCNS DisordersGenetics